Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 5, Pages e1308616
Publisher
Informa UK Limited
Online
2017-04-01
DOI
10.1080/2162402x.2017.1308616
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
- (2016) Meromit Singer et al. CELL
- Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages
- (2016) Lifeng Li et al. INTERNATIONAL JOURNAL OF CANCER
- TGF 1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
- (2016) B. V. Park et al. Cancer Discovery
- TGFβ-dependent expression of PD-1 and PD-L1 controls CD8+ T cell anergy in transplant tolerance
- (2016) Marije Baas et al. eLife
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
- (2015) Mario E. Lacouture et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming
- (2015) Taryn L. Osmond et al. JOURNAL OF IMMUNOLOGY
- TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses
- (2015) Tomohisa Okamura et al. Nature Communications
- PD-1 induction through TCR activation is partially regulated by endogenous TGF-β
- (2014) Raja Rekik et al. Cellular & Molecular Immunology
- A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer
- (2014) ALLEN COHN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- IFN- Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
- (2011) S. Terawaki et al. JOURNAL OF IMMUNOLOGY
- Systemic Inhibition of Transforming Growth Factor- in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
- (2009) R. Ueda et al. CLINICAL CANCER RESEARCH
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- TGF-β3 and cancer: A review
- (2009) H.G. Laverty et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Blockade of TGF-β enhances tumor vaccine efficacy mediated by CD8+T cells
- (2009) Shun Takaku et al. INTERNATIONAL JOURNAL OF CANCER
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Systemic Blockade of Transforming Growth Factor- Signaling Augments the Efficacy of Immunogene Therapy
- (2008) S. Kim et al. CANCER RESEARCH
- Tumor-Induced Immune Suppression of In vivo Effector T-Cell Priming Is Mediated by the B7-H1/PD-1 Axis and Transforming Growth Factor
- (2008) S. Wei et al. CANCER RESEARCH
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now